Catalog Number: HEP-003-ABCB11-a
pixHep PFIC2 (Progressive Familial Intrahepatic Cholestasis Type 2) Model
iPSC-derived hepatocytes modeling bile acid transport and cholestatic dysfunction.
- Cryopreserved vials (1 × 10⁶ viable cells per vial) carrying ABCB11 D482G mutation
- Show reduced bile acid export and canalicular polarization defects
- Enable drug screening and mechanistic studies in cholestasis pathways via pixCellServices
Place your Order
The PFIC2 pixHep™ model carries loss-of-function ABCB11 mutations, leading to impaired bile acid export and cholestatic injury.
It enables study of bile acid metabolism, inflammatory signalling, and therapeutic rescue.
Reduced/absent BSEP localisation confirmed by immunostaining.
Intracellular bile acid accumulation measured by LC–MS.
Compatible with drug, gene, or cell therapy evaluation.
Isogenic controls for direct comparison.
Technical Data & Functional Validation
ABCB11 D482G Genotypic Validation

Successful Differentiation to pixHep Hepatocytes


Reduced ABCB11 mRNA and Protein Expression

Reduced Bile Acid Transport

Streamline Your Research
Ready to Turn Your Cells Into Data?
Our pixCell portfolio seamlessly integrates into custom data generation projects—from functional assays (pixCellServices) to phenomic analysis (pixCellPaint)—delivering ready-to-use data at your fingertips.











